You are not authorized to access this page.
Search Within

MSK Grad Students

Formats
  1. Journal Article (1685)
  2. Meeting Abstract (991)
  3. Review (110)
  4. Editorial (43)
  5. Research Letter (37)
  6. Miscellaneous (21)
  7. Correspondence (15)
  8. Conference Paper (12)
  9. Book Section (9)
  10. Guidelines (6)
Groups
  1. GSK Faculty (2053)
  2. Department of Medicine (1647)
  3. Sloan Kettering Institute Postdocs (1633)
  4. Sloan Kettering Institute Faculty (1330)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1201)
  6. Center for Hematologic Malignancies (1143)

More Groups

People
  1. Sergio Giralt (401)
  2. Miguel-Angel Perales (386)
  3. Parastoo Dahi (305)
  4. Sean Devlin (286)
  5. Doris Ponce (257)
  6. Roni Tamari (214)

More People

Years
  1. 2025 (163)
  2. 2024 (275)
  3. 2023 (313)
  4. 2022 (334)
  5. 2021 (289)
  6. 2020 (378)

More Years

Publications
  1. Blood (311)
  2. Biology of Blood and Marrow Transplantation (165)
  3. Cancer Research (133)
  4. Journal of Clinical Oncology (130)
  5. Nature Communications (96)
  6. Nature (89)

More Publications

Publishers
  1. Nature Publishing Group (447)
  2. American Society of Hematology (350)
  3. Elsevier Inc. (299)
  4. Cell Press (280)
  5. American Association for Cancer Research (269)
  6. American Society of Clinical Oncology (149)

More Publishers

Results (2929)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
    Journal Article

    McIntyre, C. A.; Grimont, A.; Park, J.; Meng, Y.; Sisso, W. J.; Seier, K.; Jang, G. H.; Walch, H.; Aveson, V. G.; Falvo, D. J.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Phase 2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate (ISAC) BDC-1001 (trastuzumab imbotolimod) plus /- pertuzumab (P) in patients (pts) with HER2-positive metastatic breast cancer (MBC) previously treated with trastuzumab deruxtecan (T-DXd)
    Meeting Abstract

    Pegram, M. D.; Calfa, C.; Chen, C.; CorteĢs Salgado, A.; Heeke, A. L.; Kang, I.; Pistilli, B.; Pohlmann, P. R.; Rugo, H. S.; Saura, C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase I/II first-in-human study to evaluate the safety and efficacy of tissue factor-ADC MRG004A in patients with solid tumors
    Meeting Abstract

    Park, W.; Zhang, J.; Dayyani, F.; Shan, J.; Liu, R.; Guo, R.; O'Reilly, E. M.; Liu, Z.; Gao, S.; Wu, X.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Biomarkers in a phase 1b study of investigational microbiome therapeutic SER-155 in adults undergoing allogeneic hematopoietic cell transplantation (allo-HCT)
    Meeting Abstract

    Ponce, D. M.; Pandian, S.; van den Brink, M. R. M.; Kosuri, S.; Khera, N.; DeFilipp, Z. M.; Tejura, B.; Lichter, D. I.; Chafee, M.; Bardhan, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real world outcomes of sequential ADC therapy in metastatic breast cancer: Patients treated with sacituzumab govitecan and trastuzumab deruxtecan
    Meeting Abstract

    Mai, N.; Klar, M.; Ferraro, E.; Bromberg, M.; Chen, Y.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Walsh, E. M.; Drago, J. Z.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer (PDAC): Long-term outcomes and correlative insights
    Meeting Abstract

    Keane, F.; Tuli, R.; O'Connor, C. A.; Schwartz, C.; Park, W.; Varghese, A. M.; Perry, M.; Singhal, A.; Vardhana, S.; Hendifar, A. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Personalized circulating tumor DNA for minimal residual disease and dynamic assessment in patients undergoing neoadjuvant chemotherapy for breast cancer: Preliminary analysis from MSK-LINC
    Meeting Abstract

    Kim, H. K.; An, J. A. R.; Smith, C. G.; Kim, J.; Cabel, L.; Moiso, E.; Ferraro, E.; Safonov, A.; Nelson, K.; Szuhany, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes
    Meeting Abstract

    Keane, F.; Moss, D.; O'Connor, C. A.; Perry, M.; Chou, J. F.; Crowley, F.; Saxena, P.; Chan, A.; Park, W.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Genomic biomarkers of CNS-specific outcomes in patients with breast cancer brain metastases
    Meeting Abstract

    Khatri, I. S.; Eichholz, J.; Boe, L. A.; Safonov, A.; Smith, D. R.; Ferraro, E.; Shen, J.; Imber, B. S.; Yu, Y.; Yamada, Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Somatic mismatch repair deficiency in pancreas cancer (PC): Immune checkpoint blockade (ICB) outcomes and exploratory genomic analyses
    Meeting Abstract

    O'Connor, C. A.; Harrold, E.; Lin, Y. T.; Walch, H. S.; Gazzo, A.; Kane, S. R.; Keane, F.; Schoenfeld, J. D.; Moss, D.; Suehnholz, S. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save